Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ann Church
Observed institutions:
Quotient Clinical (United Kingdom),
Quotient Sciences Limited (United Kingdom)
OpenAlex ID:
A5110116626
Pilot Study of Nasal Morphine-Chitosan for the Relief of Breakthrough Pain in Patients With Cancer
2002
·
Hilary Pavis
, Andrew Wilcock
, et al.
·
Journal of Pain and Symptom Management
·
80
PDF
Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers
2011
·
Kevin Smith
, Michael Hopp
, et al.
·
Expert Opinion on Investigational Drugs
·
55
Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect
2017
·
Tamás Solymosi
, Zsolt Ötvös
, et al.
·
Cancer Chemotherapy and Pharmacology
·
26
A Microdosing Study to Assess the Oral Absorption of ^ C-EM 1421 in Healthy Male Subjects
2007
·
Lloyd Stevens
, Neil Frazer
, et al.
·
薬剤学
·
1
A Case Series of Hypopigmented Confluent and Reticulated Papillomatosis.
2026
·
Fahad Siddiqui
, Ann Church
, et al.
·
PubMed Central
PDF
Novel formulation of abiraterone acetate with significantly higher bioavailability and eliminated food effect might allow higher abiraterone exposure and better patient outcome.
2018
·
Hristos Glavinas
, Tamás Solymosi
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
6
Citation count:
162
H-index:
3
I10-index:
3
Year
Topic
Type